BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9340870)

  • 21. [Genetic predisposition to Alzheimer's disease].
    Staufenbiel M; Pombo-Villar E
    Rev Neurol; 1997 Aug; 25(144):1285-8. PubMed ID: 9340164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.
    Luedecking-Zimmer E; DeKosky ST; Chen Q; Barmada MM; Kamboh MI
    Hum Genet; 2002 Oct; 111(4-5):443-51. PubMed ID: 12384789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic heterogeneity of Alzheimer's disease: complexity and advances.
    Lambert JC; Amouyel P
    Psychoneuroendocrinology; 2007 Aug; 32 Suppl 1():S62-70. PubMed ID: 17659844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular genetics of Alzheimer's disease--presenilin and other genes].
    Tabira T
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1095-6. PubMed ID: 9577654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
    Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
    J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples.
    Cai X; Stanton J; Fallin D; Hoyne J; Duara R; Gold M; Sevush S; Scibelli P; Crawford F; Mullan M
    Am J Med Genet; 1997 Apr; 74(2):202-3. PubMed ID: 9129725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors of Alzheimer's disease. Epidemiologic approach].
    Alpérovitch A; Berr C
    Bull Acad Natl Med; 1996 Oct; 180(7):1673-80; discussion 1680-5. PubMed ID: 9102150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody against the polymorphic site distinguishes apolipoprotein E4 from other isoforms.
    Nukina N; Uchida K; Sakamoto T; Ide K; Kanazawa I
    Biochem Biophys Res Commun; 1995 Nov; 216(2):467-72. PubMed ID: 7488135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular genetics of apolipoprotein E and its receptors, implications for genetic risk factors of Alzheimer's disease].
    Okuizumi K; Tsuji S
    Tanpakushitsu Kakusan Koso; 1996 Aug; 41(10):1460-4. PubMed ID: 8741397
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial Alzheimer's disease. Evidences for clinical and genetic heterogeneity.
    Bergamini L; Pinessi L; Rainero I; Brunetti E; Cerrato P; Cosentino L; Vaula G; Bruni AC; Ermio C; Gei G
    Acta Neurol (Napoli); 1991 Dec; 13(6):534-8. PubMed ID: 1805554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of a neuropathologically verified familial Alzheimer's cohort with onset in the fourth decade: comparison with senile onset Alzheimer's disease and etiopathogenic implications.
    Reisberg B; Ferris SH; Franssen E; Jenkins EC; Wisniewski KE
    Prog Clin Biol Res; 1989; 317():43-54. PubMed ID: 2690108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and its use in Alzheimer's disease.
    Lee JH; Mayeux R
    Psychopharmacol Bull; 2007; 40(4):132-44. PubMed ID: 18227783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view.
    Kakulas BA; van Bockxmeer FM
    Ann Neurol; 1995 Dec; 38(6):966-7. PubMed ID: 8526475
    [No Abstract]   [Full Text] [Related]  

  • 37. A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset.
    Lendon CL; Myers A; Cumming A; Goate AM; St Clair D
    Neurosci Lett; 1997 Jun; 228(3):212-4. PubMed ID: 9218645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inheritance of Alzheimer's disease: a new interpretation.
    Fitch N; Becker R; Heller A
    Ann Neurol; 1988 Jan; 23(1):14-9. PubMed ID: 2964224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Apolipoprotein E and Alzheimer's disease].
    Lahoz C; Ordovás JM
    Rev Clin Esp; 1997 Feb; 197(2):73-4. PubMed ID: 9213859
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein E and the cost of Alzheimer's disease.
    Frisoni GB; Bianchetti A; Trabucchi M
    Int J Geriatr Psychiatry; 1997 May; 12(5):588-9. PubMed ID: 9193971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.